Key Takeaways
- • Daytona leads AI infrastructure wave: The cloud infrastructure platform for AI agents secured $48.3M in venture funding, bringing total equity raised to $86.3M. The company enables autonomous tool and code execution in isolated environments, backed by FirstMark, 500 Global, Pace Capital, e2vc, and Datadog.
- • Healthcare AI attracts institutional capital: Flagler Health closed a $50.0M Series B round, reaching $58.5M in total funding. The physician-assistance platform uses patient data and AI to recommend treatment strategies, with backing from Bessemer Venture Partners, Alumni Ventures, and SignalFire among others.
- • Network Bio matches $50M threshold: Network Bio also secured $50M in August 2026 funding, indicating strong investor appetite for life sciences and healthcare technology solutions.
- • August 2026 reflects AI-infrastructure focus: The month's largest deals concentrated in artificial intelligence, cloud infrastructure, and healthcare—sectors driving the "physical layer of AI" infrastructure buildout that defined H1 2026 funding activity.
- • NYC remains venture capital hub: Eight NYC startups raised over $116M in August 2026's largest rounds, demonstrating the city's continued dominance in early-stage technology and life sciences capital deployment.
Summary
August 2026 marked a significant month for New York City venture capital activity, with the seven largest funding rounds spanning healthcare, artificial intelligence, cloud infrastructure, and adjacent sectors. The funding landscape reflected broader investor trends favoring the technical infrastructure supporting AI advancement and healthcare innovation.
Daytona, a cloud infrastructure platform enabling AI agents to execute tools and code autonomously in secure, isolated environments, commanded the most attention among pure AI infrastructure plays. The company, founded in 2023 by Goran Draganic, Ivan Burazin, and Vedran Jukic, secured $48.3M in venture funding, bringing its total equity capital to $86.3M. The round included backing from established venture firms FirstMark, 500 Global, Pace Capital, and e2vc, as well as strategic investor Datadog, signaling confidence in the infrastructure layer supporting autonomous AI systems.
Healthcare and life sciences applications of AI demonstrated equally strong capital attraction. Flagler Health, which assists physicians by recommending treatment strategies based on patient data and artificial intelligence, raised $50.0M in Series B funding, accumulating $58.5M in total equity raised since its 2023 founding. The round included participation from Bessemer Venture Partners, Alumni Ventures, Tribeca Venture Partners, SignalFire, and PROOF, with additional investors 186 Ventures, Offscript, and Streamlined. Founders Albert Katz, Leon Anijar, and Will Hu built the company to address clinical decision-making through data-driven recommendations.
Network Bio similarly achieved the $50M funding threshold in August, indicating sustained institutional appetite for life sciences innovation. Together, these three companies alone captured approximately $148.3M in August 2026 funding, exemplifying the concentration of capital in sectors enabling the AI economy and its applications across critical industries. The aggregate activity underscores investor conviction that infrastructure, healthcare, and foundational AI platforms remain priority deployment areas amid broader market evolution.
Daytona, a cloud infrastructure platform enabling AI agents to execute tools and code autonomously in secure, isolated environments, commanded the most attention among pure AI infrastructure plays. The company, founded in 2023 by Goran Draganic, Ivan Burazin, and Vedran Jukic, secured $48.3M in venture funding, bringing its total equity capital to $86.3M. The round included backing from established venture firms FirstMark, 500 Global, Pace Capital, and e2vc, as well as strategic investor Datadog, signaling confidence in the infrastructure layer supporting autonomous AI systems.
Healthcare and life sciences applications of AI demonstrated equally strong capital attraction. Flagler Health, which assists physicians by recommending treatment strategies based on patient data and artificial intelligence, raised $50.0M in Series B funding, accumulating $58.5M in total equity raised since its 2023 founding. The round included participation from Bessemer Venture Partners, Alumni Ventures, Tribeca Venture Partners, SignalFire, and PROOF, with additional investors 186 Ventures, Offscript, and Streamlined. Founders Albert Katz, Leon Anijar, and Will Hu built the company to address clinical decision-making through data-driven recommendations.
Network Bio similarly achieved the $50M funding threshold in August, indicating sustained institutional appetite for life sciences innovation. Together, these three companies alone captured approximately $148.3M in August 2026 funding, exemplifying the concentration of capital in sectors enabling the AI economy and its applications across critical industries. The aggregate activity underscores investor conviction that infrastructure, healthcare, and foundational AI platforms remain priority deployment areas amid broader market evolution.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.